首页|附子汤加味联合美托洛尔缓释片治疗冠心病心绞痛临床观察

附子汤加味联合美托洛尔缓释片治疗冠心病心绞痛临床观察

扫码查看
目的:观察附子汤加味联合美托洛尔缓释片治疗冠心病心绞痛(CHD-AP)的效果.方法:75例根据单双数法分为对照组37例及观察组38例.两组均用美托洛尔缓释片治疗,观察组加用附子汤加味治疗.结果:总有效率观察组高于对照组(P<0.05).治疗后观察组中医证候积分低于对照组(P<0.05).治疗后观察组QRS电压值高于对照组,而QTc间期、QRS时限值低于对照组(P<0.05).治疗后观察组LVEF、CO心功能指标高于对照组(P<0.05).结论:附子汤加味联合美托洛尔缓释片治疗CHD-AP可提高疗效.
Objective:To observe the effect of modified Fuzi decoction combined with metoprolol sustained-release tablets in the treatment of coronary heart disease angina pectoris(CHD-AP).Methods:Seventy-five cases were divided into the control group(37 cases)and the observation group(38 cases)according to the odd and even number method.Both groups were treated with metoprolol sustained-release tablets,and the observation group were treated with modified Fuzi Decoction.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).After treatment,the scores of TCM syndromes in the observation group were lower than those in the control group(P<0.05).After treatment,the QRS voltage value of the observation group was higher than that of the control group,while the QTc interval and QRS time limit were lower than those of the control group(P<0.05).After treatment,the LVEF and CO cardiac function indexes of the observation group were higher than those of the control group(P<0.05).Conclusion:Modified Fuzi Decoction combined with metoprolol sustained-release tablets could improve the curative effect in the treatment of CHD-AP.

Coronary heart disease angina pectorisModified Fuzi DecoctionMetoprolol sustained-release tablets

陈丽丽

展开 >

河南省商丘市中医院心内科,河南 商丘 476000

冠心病心绞痛 附子汤加味 美托洛尔缓释片

2024

实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
年,卷(期):2024.40(5)
  • 11